Click Here for 5% Off Your First Aladdin Purchase!

GSK1059615 - ≥98%, high purity , PI3-kinase class I inhibitor, CAS No.958852-01-2, PI3-kinase class I inhibitor

  • Moligand™
  • ≥98%
Item Number
G127955
Grouped product items
SKUSizeAvailabilityPrice Qty
G127955-5mg
5mg
In stock
$75.90
G127955-25mg
25mg
In stock
$342.90
G127955-100mg
100mg
In stock
$706.90

Potent PI 3-kinase inhibitor

Basic Description

SynonymsGSK1059615|958852-01-2|GSK-1059615|GSK 1059615|(Z)-5-((4-(pyridin-4-yl)quinolin-6-yl)methylene)thiazolidine-2,4-dione|UNII-07YMO87363|GSK-615|07YMO87363|5-[[4-(4-Pyridinyl)-6-quinolinyl]methylene]-2,4-thiazolidenedione|(5Z)-5-[(4-pyridin-4-ylquinolin-6-yl
Specifications & PurityMoligand™, ≥98%
Biochemical and Physiological MechanismsPotent inhibitor of PI 3-kinaseα(PI3Kα) (IC50= 2 nM). Inhibits proliferation in BT474 cells and attenuates MAPK signaling.
Storage TempStore at 2-8°C
Shipped InWet ice
GradeMoligand™
Action TypeINHIBITOR
Mechanism of actionPI3-kinase class I inhibitor
Product Description

GSK1059615 is a dual inhibitor of PI3Kα/β/δ/γ (reversible) and mTOR with IC50 of 0.4 nM/0.6 nM/2 nM/5 nM and 12 nM, respectively.
A potent inhibitor of PI 3-kinase and FRAP (mTOR)

Product Properties

ALogP3

Names and Identifiers

Pubchem Sid488200355
Pubchem Sid Urlhttps://pubchem.ncbi.nlm.nih.gov/substance/488200355
IUPAC Name (5Z)-5-[(4-pyridin-4-ylquinolin-6-yl)methylidene]-1,3-thiazolidine-2,4-dione
INCHI InChI=1S/C18H11N3O2S/c22-17-16(24-18(23)21-17)10-11-1-2-15-14(9-11)13(5-8-20-15)12-3-6-19-7-4-12/h1-10H,(H,21,22,23)/b16-10-
InChi Key QDITZBLZQQZVEE-YBEGLDIGSA-N
Canonical SMILES C1=CC2=NC=CC(=C2C=C1C=C3C(=O)NC(=O)S3)C4=CC=NC=C4
Isomeric SMILES C1=CC2=NC=CC(=C2C=C1/C=C\3/C(=O)NC(=O)S3)C4=CC=NC=C4
PubChem CID 23582824
Molecular Weight 333.36

Certificates

Certificate of Analysis(COA)

Enter Lot Number to search for COA:

To view the certificate results,please click on a Lot number.For Lot numbers from past orders,please use our order status section

6 results found

Lot NumberCertificate TypeDateItem
C2313754Certificate of AnalysisDec 09, 2022 G127955
C2313756Certificate of AnalysisDec 09, 2022 G127955
C2316751Certificate of AnalysisDec 09, 2022 G127955
C2316753Certificate of AnalysisDec 09, 2022 G127955
C2316755Certificate of AnalysisDec 09, 2022 G127955
C2316762Certificate of AnalysisDec 09, 2022 G127955

Chemical and Physical Properties

SolubilitySolvent:DMSO, Max Conc. mg/mL: 3.33, Max Conc. mM: 10
Refractive Index1.76

Related Documents

References

1. Xie J, Li Q, Ding X, Gao Y.  (2017)  GSK1059615 kills head and neck squamous cell carcinoma cells possibly via activating mitochondrial programmed necrosis pathway..  Oncotarget,  (31): (50814-50823).  [PMID:28881606]
2. Knight SD, Adams ND, Burgess JL, Chaudhari AM, Darcy MG, Donatelli CA, Luengo JI, Newlander KA, Parrish CA, Ridgers LH et al..  (2010)  Discovery of GSK2126458, a Highly Potent Inhibitor of PI3K and the Mammalian Target of Rapamycin..  ACS Med Chem Lett,  (1): (39-43).  [PMID:24900173]

Solution Calculators